DRK Pharma and Intermediates is a bulk drug and intermediate manufacturer established in early 2017. In late 2019 the firm was converted into DRK Labs Private Limited. The company serves the Pharmaceuticals, Veterinary and Intermediates segments with the sole aim of satisfaction of the end users.
Our products enjoy good fame in the domestic market because of high quality standards, timely deliveries and competitive cost. Our goal is to provide every customer with products having zero defects, representing the best mix of performance and value addition.
We are committed to customer satisfaction by providing high standards of Intermediates and APIs, Fine Chemicals and Speciality Chemicals competitively, with compliance on cGMP, safety and environmental requirements.
“Our QMS is dynamic to achieve genesis of success.”
At DRK Labs, quality is not a sporadic affair but a sustained effort. We continuously upgrade our processes and products through standard operating procedures and put the purity profile of every product through a battery of stringent quality checks — aiming to be more accurate and stringent than the specifications.
To be an integrated pharmaceutical company that contributes to quality healthcare and becomes a significant player by providing consistent high-quality products through continuous improvement and innovation. To develop environment-friendly products for a better tomorrow.
To provide cost-effective products with consistent quality within scheduled time along with value addition to our customers. To achieve excellence in our own products and service to help build long-term relations with our customers.
DRK Labs offers a wide range of APIs, intermediates, fine chemicals and speciality chemicals, plus custom-built intermediates for specific customers — in both old and new ranges.